Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals Inc (SNDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kynam Capital Derrick Tang | 5,722,057 | $117,473,830 | +2% | 9.06% |
| 2. | VenBio Select Advisor Kurt Von Emster | 3,888,437 | $79,829,612 | -8% | 1.06% |
| 3. | Eversept Partners Kamran Moghtaderi | 3,613,631 | $74,187,844 | +16% | 5.08% |
| 4. | Avidity Partners Management David Witzke And Michael Gregory | 3,335,000 | $68,467,550 | +39% | 2.9% |
| 5. | Point72 Asset Management Steve Cohen | 2,782,853 | $57,131,969 | +35% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.03 | 1,250 | 52,623 | 2024-06-14 | Filing | ||
| $15.46 | 500 | 15,666 | 2021-04-26 | Filing | ||
| $14.11 | 13,967 | 43,300 | 2021-04-22 | Filing | ||
| $8.00 | 12,500 | 43,900 | 2020-02-04 | Filing | ||
| $5.40 | 11,000 | 31,400 | 2019-10-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.27 | 52,855 | 17,836 | 2023-08-09 | Filing | ||
| $20.45 | 24,000 | 48,000 | 2023-08-02 | Filing | ||
| $20.46 | 24,000 | 48,000 | 2023-08-02 | Filing | ||
| $20.46 | 35,000 | 48,000 | 2023-08-02 | Filing | ||
| $20.40 | 52,855 | 17,836 | 2023-07-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,585,221 | $163,916,627 | 0.03% | |
| 2. | 7,015,548 | $151,605,991 | 0% | |
| 3. | 5,016,224 | $108,400,601 | 0% | |
| 4. | 4,335,353 | $93,686,978 | 0% | |
| 5. | 1,664,306 | $35,965,653 | 0% |
News See All
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.99.
12 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2022 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Fourth Quarter 2022 Conference Call. Today's call is being recorded.
Billionaire Hedge Funds
